These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 15521096)

  • 1. Swiss patent proposal prompts criticism.
    Burgermeister J
    Nat Biotechnol; 2004 Oct; 22(10):1323. PubMed ID: 15521096
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 3. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 4. Cabilly patent finale.
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):846. PubMed ID: 18688222
    [No Abstract]   [Full Text] [Related]  

  • 5. India's IP snub.
    Jayaraman KS
    Nat Biotechnol; 2008 Apr; 26(4):362. PubMed ID: 18392000
    [No Abstract]   [Full Text] [Related]  

  • 6. Negotiating the RNAi patent thicket.
    Schmidt C
    Nat Biotechnol; 2007 Mar; 25(3):273-5. PubMed ID: 17344871
    [No Abstract]   [Full Text] [Related]  

  • 7. US policy may encourage counterfeit drugs.
    Bouchie A
    Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 9. Protecting rights to early-stage technology.
    Shuster MJ; Su H; Blaug S
    Nat Biotechnol; 2003 Jun; 21(6):701-3. PubMed ID: 12776151
    [No Abstract]   [Full Text] [Related]  

  • 10. Owning the secret of life: biotechnology and property rights revisited.
    Yelpaala K
    McGeorge Law Rev; 2000; 32(1):111-219. PubMed ID: 15709267
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
    Lu DL; Kowalski TJ; Jarecki-Black J
    Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040
    [No Abstract]   [Full Text] [Related]  

  • 12. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
    Garber K
    Science; 2006 May; 312(5775):827. PubMed ID: 16690824
    [No Abstract]   [Full Text] [Related]  

  • 13. Roche faces charges over Taq patent claim.
    Abbott A
    Nature; 1996 Aug; 382(6593):660. PubMed ID: 8751427
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent pools and standard setting in diagnostic genetics.
    Ebersole TJ; Guthrie MC; Goldstein JA
    Nat Biotechnol; 2005 Aug; 23(8):937-8. PubMed ID: 16082359
    [No Abstract]   [Full Text] [Related]  

  • 15. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

  • 16. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 17. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent watch: Progress in three key patent disputes in 2009.
    Nat Rev Drug Discov; 2010 Jan; 9(1):12-3. PubMed ID: 20050395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.